drugset / Trial / NCT03140631

Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation

NCT03140631

Phase 4 Completed 153 enrolled University of Michigan
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the safety, efficacy and efficiency of rapid anticoagulation reversal with protamine sulfate versus routine activated clotting time (ACT) monitoring in patients undergoing catheter based ablation of atrial fibrillation.

Timeline

Start
2017-03-23
Primary completion
2017-11-16
Completion
2018-04-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Protamine Sulfate Unknown

Indications